Last reviewed · How we verify

NCT04782531: RESPIFLUX

Variations of Portal Flow During the Respiratory Cycle in Healthy Volunteers

Completed NA Last updated 29 May 2025
What this trial tests

NA trial testing peripheral ECG in Respiratory Amplitude in 22 participants. Completed in 7 October 2024.

Timeline
1 March 2021
Primary endpoint
1 March 2023
7 October 2024

Quick facts

Lead sponsorCentre Hospitalier Universitaire, Amiens
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment22
Start date1 March 2021
Primary completion1 March 2023
Estimated completion7 October 2024
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire, Amiens

Who can join

18 and older, any sex, with Respiratory Amplitude or Portal Blood Flow. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The analysis of portal vein blood flow is important when assessing the severity and progression of liver disease. It is important to understand normal liver regulation in order to appreciate the evaluation of the effect of treatment during the disease progression. The influence of respiration on hepatic hemodynamics is still poorly understood, although some studies have shown a significant impact. The purpose of this project is to quantify the blood flow variations in the portal vein at different positions during the respiratory cycle by using a fast MRI sequence and an Echo Planar (EPI) acquisition.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Centre Hospitalier Universitaire, Amiens trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04782531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing